All News

    Progress Reported in Phase 1 Trial of CLD-101 for Recurrent Glioma

    March 26th 2025, 4:00pm

    Article

    A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral doses.

    FDA Approves Cabometyx for Some Neuroendocrine Tumors

    March 26th 2025, 1:44pm

    Article

    The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.

    Navigating a Colorectal Cancer Diagnosis at a Young Age

    March 26th 2025, 1:00pm

    Article

    Melissa Ursini discussed her experience with a colorectal cancer diagnosis at age 37, highlighting her insights during Colorectal Cancer Awareness Month.

    EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

    March 25th 2025, 9:00pm

    Article

    The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.

    Top 3 Takeaways From ASCO GU 2025

    March 25th 2025, 8:16pm

    Video

    Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium.

    New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application

    March 25th 2025, 7:05pm

    Article

    EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach this stage.

    Navigating a Diagnosis of Diabetes and Chronic Lymphocytic Leukemia

    March 25th 2025, 5:00pm

    Article

    Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm working to balance both.

    Olvi-Vec Shows Responses and Tolerable Safety in Small Cell Lung Cancer

    March 25th 2025, 4:14pm

    Article

    Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

    First Patient Dosed with Efti in Phase 3 Trial for Non-Small Cell Lung Cancer

    March 25th 2025, 3:34pm

    Article

    The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced non-small cell lung cancer.

    Raising Awareness for Colorectal Cancer, On the Rise in Younger Adults

    March 25th 2025, 1:00pm

    Article

    During Colorectal Cancer Awareness Month, Dr. Shyam Thakkar discussed rates of this disease in young adults, the role of AI and disparities in care.